Variable | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|
IRR (95% CI) | p | IRR (95% CI) | p | IRR (95% CI) | p | |
Comorbid mental disorders | ||||||
No comorbidity | 1 (Ref) | 1 (Ref) | 1 (Ref) | |||
Psychosis/bipolar disorder (F20-F31) | 0.38 (0.31–0.49) | < 0.001 | 0.39 (0.31–0.49) | < 0.001 | 0.67 (0.53–0.85) | < 0.001 |
Depressive/anxiety disorder (F32-F49) | 0.57 (0.48–0.68) | < 0.001 | 0.55 (0.46–0.66) | < 0.001 | 0.86 (0.72–1.03) | 0.106 |
Personality disorders (F60-F69) | 0.32 (0.24–0.43) | < 0.001 | 0.35 (0.26–0.49) | < 0.001 | 0.56 (0.42–0.77) | < 0.001 |
Gender | ||||||
Male | 1 (Ref) | 1 (Ref) | ||||
Female | 0.89 (0.75–1.05) | 0.165 | 0.96 (0.0.82–1.12) | 0.583 | ||
Age | 1.01 (1.01–1.02) | < 0.001 | 1.01 (1.00–1.01) | 0.083 | ||
Substance use disorder | ||||||
Alcohol related disorders (F10) | 1 (Ref) | 1 (Ref) | ||||
Opiate related disorders (F11) | 0.87 (0.69–1.10) | 0.237 | 1.00 (0.81–1.25) | 0.988 | ||
Cannabis related disorders (F12) | 1.02 (0.76–1.39) | 0.898 | 1.05 (0.80–1.39) | 0.745 | ||
Sedative, hypnotic, or anxiolytic related disorders (F13) | 1.36 (1.03–1.82) | 0.032 | 1.35 (1.04–1.78) | 0.023 | ||
Other substance related disorders (F14-F16) | 1.03 (0.75–1.44) | 0.858 | 1.03 (0.76–1.41) | 0.855 | ||
Multiple substance related disorders (F19) | 1.08 (0.86–1.37) | 0.491 | 1.11 (0.89–1.39) | 0.317 | ||
Deliberate self-harm | ||||||
No deliberate self-harm last year | 1 (Ref) | 1 (Ref) | ||||
Deliberate self-harm last year | 0.78 (0.61–1.01) | 0.049 | 0.94 (0.74–1.20) | 0.593 | ||
Number of admissions | ||||||
0 | 1 (Ref) | |||||
1 | 0.74 (0.61–0.91) | 0.002 | ||||
≥ 2 | 0.37 (0.37–0-56) | < 0.001 | ||||
Number of outpatient contacts | ||||||
0 | 1 (Ref) | |||||
1–10 | 0.64 (0.50–0.82) | < 0.001 | ||||
≥ 11 | 0.28 (0.22–0.37) | < 0.001 |